{{refimprove|date=April 2010}}

{{Drugbox
| verifiedrevid =
| IUPAC_name = 3-[2-({(1''S'',2''R'',3''S'')-3-[4-(Pentylcarbamoyl)-1,3-oxazol-2-yl]-7-oxabicyclo[2.2.1]hept-2-yl}methyl)phenyl]propanoic acid
| image = Ifetroban.svg

<!--Clinical data-->
| tradename =
| pregnancy_category =
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| metabolism =
| excretion =

<!--Identifiers-->
| CAS_number = 143443-90-7
| ATC_suffix = None
| PubChem = 23724921
| DrugBank =
| ChemSpiderID = 58452
| ChEMBL = 2146062
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = E833KT807K
| KEGG = D04500
| synonyms =

<!--Chemical data-->
| C=25 | H=32 | N=2 | O=5
| molecular_weight = 440.53 g/mol
| smiles = O=C(NCCCCC)c1nc(oc1)[C@@H]4C2O[C@@H](CC2)[C@@H]4Cc3ccccc3CCC(=O)O
}}

'''Ifetroban''' is a potent and selective [[thromboxane receptor antagonist]].<ref>{{cite journal|last1=Dockens|first1=RC|last2=Santone|first2=KS|last3=Mitroka|first3=JG|last4=Morrison|first4=RA|last5=Jemal|first5=M|last6=Greene|first6=DS|last7=Barbhaiya|first7=RH|title=Disposition of Radiolabeled Ifetroban in Rats, Dogs, Monkeys, and Humans|journal=Drug Metabolism and Disposition: the Biological Fate of Chemicals|date=August 2000|volume=28|issue=8|pages=973â€“80|pmid=10901709|url=http://dmd.aspetjournals.org/content/dmd/28/8/973.full.pdf|accessdate=5 October 2016}}</ref>

==Synthesis==
[[File:Ifetroban synthesis.png|thumb|center|700px|Ifetroban synthesis: Drugs Future (c.f. Lednicer book 6).]]

==References==
{{Reflist}}

{{Prostanoidergics}}

[[Category:Oxazoles]]

{{drug-stub}}